Skip to main content
. 2017 Nov 1;26(21):1528–1539. doi: 10.1089/scd.2017.0150

Table 1.

Primary Refinements of the Embryonic Stem Cell Test

Chemicals Cell line Exposure duration Differences from Spielmann's original EST Findings Reference
15 pharmaceuticals DBA/1lacJ murine derived ESCs, 3T3 A31 Cytotoxicity assay: 7 days Different ESC line Other murine ESC lines can replace D3 in the EST; false positives and negatives can still be significant 7
Differentiation assay: 10 days
Penicillin G, 5-FU, RA, diphenylhydantoin, valproic acid, thalidomide Balb/c 3T3, D3 Cell viability: 10 days Involvement of multiple marker genes of other lineages (neurogenesis, osteogenesis, and chondrogenesis markers) First time to include multiple gene expressions in the EST; results are promising and open to further improvement and optimization 8
Differentiation assays (contraction assay and collection of RNA samples): 10 days
6-Aminonicotinamide, 5-FU, methylmercury chloride, hydroxyl urea, valproic acid, boric acid, methoxyacetic acid, lithium chloride, penicillin G, saccharin, diphenhydramine, acrylamide D3 Cell viability assay: 6 days Instead of being seeded in 24-well plates, mESCs are seeded and cultured in low attachment 96-well plate to facilitate high-throughput tests. Introduce relative embryotoxicity potency values that are derived from the ranking of the embryotoxic potential of test compounds relative to positive controls No need for 3T3 to provide reference toxicity information. Toxicity ranking seems more reliable than the absolute classification of toxicity 9
Differentiation assay: 10 days
Monobutyl phthalate, methoxyacetic acid, valproic acid, RA, 5-FU, penicillin G D3 Cell viability assay: 3 days Use resazurin proliferation assay; involve whole-genome gene expression profiling Several genes are very sensitive and significantly dysregulated after compound exposure, which are useful as additional endpoints in the EST 10
Differentiation assay: 10 days
Triazoles, flusilazole, hexaconazole, cyproconazole, myclobutanil, triadimefon, triticonazole, 5-FU D3 Cell viability assay: 5 days Compare the EST with in vivo tests, the rat postimplantation WEC, and zebrafish embryotoxicity test The EST is able to represent developmental toxicity, and partially mimic the processes in utero 11
Differentiation assay: 10 days
9-cis-RA, 13-cis-RA, acitretin, ATRA, TTNPB, etretinate, retinol D3 Cell viability: 10 days Compare the EST with in vivo tests, the rat limb bud micromass test, and the postimplantation rat WEC The EST, although it could not completely imitate toxicological kinetics in vivo, was overall a promising in vitro alternative in toxicology 12
Cell differentiation: 10 days
Methylmercury, valproic acid, AsV, AsIII, saccharin, isoniazid, ascorbic acid D3, 3T3 Cytotoxicity: 10 days Neural differentiation instead of cardiac induction with exposure duration of 12 days. Use flow cytometry and detection of neural gene expression as endpoints Neural differentiation could serve as an alternative process in the EST. The molecular endpoints introduced in the neural differentiation-based EST were Tuj1 mRNA and protein levels 13
Neural differentiation assay: 12 days
Mono-ethlhexyl phthalate, valproic acid, methotrexate, 6-aminonicotinamde, methoxyacetic acid, penicillin G D3 Cell viability: 5 days Involvement of osteoblast differentiation and molecular endpoints to evaluate it. Comparison between osteoblast and cardiomyocyte differentiations on exposure to same chemicals Osteoblast differentiation can be an alternative to cardiogenesis in the EST, and may give different results 14
Osteoblast differentiation assay: 21 days. Cardiac differentiation assay: 10 days
Phenol, p-fluorophenol, p-heptyloxyphenol, p-mercaptophenol, p-methylketophenol D3 Cell differentiation assay: 10 days Compare the EST with in vivo tests and the WEC assay The EST gives toxicity rankings of tested phenols that are different from the rankings given by in vivo tests and the WEC assay; exposure doses in the EST have to consider the kinetics of in vivo absorption, metabolism, elimination, and excretion 15
Acealdehyde, carbamazepine, flusilazole, monoethylhexylaphthalate, penicillin G sodium salt, phenytoin D3 Cell viability test: 48 h Neural differentiation The neural differentiation-modified EST is valid; transcriptomics provides mechanistic information 16
Morphological scoring: 72 h Different exposure durations
Whole-genome expression profiling: 24 h Resazurin cell viability assay
Include genome profiling
MeHgCl, monosodium l-glutamate, penicillin G, poly-l-ornithine, sodium arsenite, sodium valproate, chlorpyrifoe-ethyl, parathion-ethyl D3 Cell viability: 4 or 5 days Differentiation: 2 or 3 days Differentiation to neural cells This method is suitable for high-throughput screening but does not necessarily represent relevant concentrations in vivo and is not applicable for acute and chronic toxicities 17
Cell proliferation tests are based on ELISA. Cell viability tests are based on CellTiter-Blue Cell Viability Assay. Involvement of βIII-Tubulin enzyme-linked immunosorbent assay
Bisphenol A, genistein, as well as combined with bisphenol A and 5-FU D3, 3T3 Cell viability test: 10 days Cell Titer 96 Aqueous One Solution Cell Proliferation Assay for cell viability test; cells are exposed to two chemicals Bisphenol A and genistein, to which we are exposed daily unintentionally, have combined embryotoxic effects that become synergistic at low concentrations 18
Differentiation assay: 10 days
38 teratogens D3 Cell viability test: 72 h Shorter exposure times; include gene expression analysis for 12 potential molecular endpoints The Molecular Embryonic Stem Cell Developmental Toxicity Assay facilitates high-throughput screenings of potential teratogens with good predictivity and concordance with in vivo data 19
39 nonteratogens Cell differentiation assay: 96 h
Monobutyl phthalate, monobenzyl phthalate, mono-(2-ethylhexyl) phthalate, monomethyl phthalate D3 Cell viability: 5 days Differentiation assay: 10 days Incorporate RNA microarray analyses as additional endpoints A total of 668 commonly expressed genes are altered after exposure, proving the validity of transcriptomics in the EST 20
5-FU, hydroxyurea, saccharin; silver nanomaterial, coated and uncoated zinc oxide, titanium and silica nanomaterials D3, 3T3 Cell viability: 10 days Skip the step of EB formation in petri dishes and transfer EBs directly to 24-well plates. Add nanomaterial once to avoid continuous accumulation in cells This simplified protocol shows to be more suitable to facilitate nanotoxicity research for medical or therapeutic nanomaterial uses 21
Cell differentiation: 10 days
6-aminonicotinamide, all-trans RA, 5-bromo-2′-deoxyuridine, dexamethasone, methoxyacetic acid, salicylic acid sodium salt, ascorbic acid, acrylamide, d-(+)-camphor, 5-FU Linearized Hand1-promoter-Luc plasmid transfected C57BL/6 mice derived ESCs Cell viability: 5 days Monitor Hand1 expression via Luciferase reporter assay, which at the same time indicates both proliferation and differentiation The expression of Hand1 by Luciferase reporter gene assay is reproducible and relatively accurate 22
Differentiation assay: 5 days
Simvastatin D3, 3T3 Cytotoxicity: 10 days. Include both EB hanging drop method and monolayer differentiation. Molecular endpoints are maker genes for each germ layer Genes of the mesodermal lineage are most sensitive to the two drugs; the hanging drop method and monolayer differentiation give rise to consistent results 23
Differentiation assay (both hanging drop method and monolayer differentiation): 10 days
Chinese herbal extracts from Atractylodes macrocephala, Coptis chinensis, Radix isatidis, Flos genkwa OG2 mESCs, BALB/c 3T3 Cell viability: 10 days Cell viability assay: CCK8 assay Atractylodes macrocephala and Radix isatidis are non-embryotoxic, Coptis chinensis is weakly embryotoxic whereas Flos genkwa is strongly embryotoxic 24
Differentiation assay: 10 days Differentiation assay based on myosin heavy chain gene expression
5-FU, RA, valproic acid, diphenhydramine, LiCl, saccharin, penicillin G D3, 3T3 Cell viability: 5 days Based on only monolayer culture with 5-day exposure. Check 16 genes for the three germ layers as endpoints for differentiation Monolayer culture is applicable in the EST with gene expression detection for three germ layers 25
Differentiation assay: 5 days

ATRA, all trans retinoic acid; EB, embryoid body; ESC, embryonic stem cell; EST, embryonic stem cell test; 5-FU, 5-fluorouracil; mESCs, mouse embryonic stem cells; RA, retinoic acid; TTNPB, (E)-4[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl]benzoic acid; WEC, whole embryo culture.